Metraipolis › archive › dc_2f3f699bda78

The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41011719
DOI
10.3390/molecules30183828
License (as archived)
solo-consultazione
Archived
2026-11-09T20:25:01.381Z
SHA-256 of the archived text
c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f
Stable URL of this page
https://metraipolis.com/documento/dc_2f3f699bda78

How to cite

The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719 — Europe PMC (en), https://europepmc.org/article/MED/41011719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f3f699bda78 (Metraipolis archive dc_2f3f699bda78, sha256 c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f)
BibTeX
@misc{dc2f3f699bda78,
  title = {The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes — Europe PMC PMID:41011719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41011719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f3f699bda78; sha256 c43eeb61b5f09106b0b97ab20a3be1b7f67697f81c67f4674e08b120bce46b6f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011719. Agents can read the archived copy with the MCP tool read_document.